Industrial Machinery & Robotics Global On demand · 24-48h

Global Automated Single-Cell Sample Preparation System Market Strategic Research Report

Global Automated Single-Cell Sample Preparation System Marke…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Automated Single-Cell Sample Preparation System Market
$8412025
10.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single-cell Isolation Systems, Single-cell Library Preparation Systems, Single-cell Dispensing Systems, Tissue Dissociation and Nuclei Preparation Systems, Integrated Multiomics Preparation Platforms, Others

By Application: Oncology Research, Immunology Research, Cell and Gene Therapy Research, Drug Discovery and Screening, Spatial Biology and Multiomics Research, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: 10x Genomics, Inc., BD Biosciences, Mission Bio, Inc., Dolomite Bio, Singleron Biotechnologies, Takara Bio Inc., S2 Genomics, Inc., Cellenion SASU, CYTENA GmbH, Sphere Fluidics Limited, Berkeley Lights, Inc. (PhenomeX), MGI Tech Co., Ltd., Standard BioTools Inc., LevitasBio, NanoCellect Biomedical, Beijing Bestopcell Medical Technology Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 132 pages
Market size 2025
$841
Million USD
Forecast CAGR
10.9%
2025-2032
Forecast 2032
$1735.1
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Automated Single-Cell Sample Preparation System market size is predicted to grow from US$ 841 million in 2025 to US$ 1,688 million in 2032; it is expected to grow at a CAGR of 10.9% from 2026 to 2032.

Automated single cell sample preparation systems are advanced life science automation platforms designed for single cell sequencing, single cell multiomics, and cellular analysis workflows. These systems are primarily used for tissue dissociation, single cell or single nucleus suspension preparation, cell isolation, microfluidic encapsulation, barcode labeling, library preparation, and upstream sample processing. Major product forms include droplet based microfluidic platforms, automated single cell library preparation systems, single cell dispensing instruments, tissue dissociation systems, and integrated multiomics preparation platforms. Core technologies involve microfluidic chips, droplet generation, acoustic dispensing, magnetic levitation separation, automated liquid handling, and combinatorial barcoding workflows. These systems are widely applied in oncology research, immunology, cell therapy, drug discovery, translational medicine, and spatial biology, where high cell viability, reproducibility, throughput, and contamination control are critical. In 2025, the global industry average gross margin was approximately 55% to 72%, while standard automated single cell preparation systems averaged about USD 50,000 to USD 250,000 per unit, and high end fully automated multiomics platforms averaged about USD 300,000 to USD 1.2 million per unit.

Automated single cell sample preparation systems are evolving from specialized research tools into critical infrastructure platforms for precision medicine and advanced life science research. Upstream activities mainly involve microfluidic chips, precision fluid control components, automated motion systems, high sensitivity detection modules, and molecular reagent technologies. Midstream segments focus on single cell isolation, automated library preparation, droplet encapsulation, and multiomics workflow integration, while downstream demand is concentrated in oncology research, immunology, cell therapy, drug discovery, translational medicine, and spatial biology applications. As single cell workflows become increasingly complex, laboratories are placing greater emphasis on throughput, reproducibility, standardization, and contamination control, accelerating the transition from exploratory academic usage toward clinical and industrial adoption.

The competitive landscape remains dominated by North American and European suppliers, although Chinese manufacturers are rapidly improving their local platform capabilities and supply chain integration. Droplet based microfluidic systems continue to represent the dominant technology route, while acoustic dispensing, magnetic levitation separation, optoelectronic manipulation, and nanowell based partitioning technologies are expanding in niche applications. Industry consolidation, platform acquisitions, and ecosystem integration have become increasingly active in recent years, particularly as vendors seek to combine single cell workflows with spatial biology, AI driven analytics, and laboratory automation systems. At the same time, fluctuations in research funding and cautious laboratory capital expenditure have extended procurement cycles for high end instruments.

Future market expansion is expected to be driven by clinical research, pharmaceutical high throughput screening, translational medicine programs, and large scale cohort studies. Automated single nucleus preparation, spatial multiomics integration, closed loop library preparation, and clinically standardized workflows are becoming major technology directions, encouraging the industry to move toward higher throughput, lower sample loss, and more fully automated processing. North America is expected to remain the primary innovation and commercialization hub, Europe maintains strong expertise in microfluidics and precision dispensing technologies, and China is experiencing rapid growth through localization efforts, hospital research infrastructure expansion, and domestic supply chain development. Despite strong long term growth potential, the industry may gradually face substitution pressure in lower end workflows from low cost reagent solutions and general laboratory automation platforms.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automated Single-Cell Sample Preparation System market?

What factors are driving Automated Single-Cell Sample Preparation System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automated Single-Cell Sample Preparation System market opportunities vary by end market size?

How does Automated Single-Cell Sample Preparation System break out by Type, by Application?

This report presents a comprehensive overview of the global Automated Single-Cell Sample Preparation System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single-cell Isolation Systems
  • Single-cell Library Preparation Systems
  • Single-cell Dispensing Systems
  • Tissue Dissociation and Nuclei Preparation Systems
  • Integrated Multiomics Preparation Platforms
  • Others

Segment by Technology Route

  • Droplet-based Microfluidics
  • Microwell-based Systems
  • Acoustic Dispensing Systems
  • Optical and Electromagnetic Manipulation Systems
  • Magnetic Levitation-based Systems
  • Others

Segment by Throughput Level

  • Low-throughput Systems (<1,000 cells/run)
  • Medium-throughput Systems (1,000–10,000 cells/run)
  • High-throughput Systems (10,000–100,000 cells/run)
  • Ultra-high-throughput Systems (>100,000 cells/run)
  • Others

Segment by Application

  • Oncology Research
  • Immunology Research
  • Cell and Gene Therapy Research
  • Drug Discovery and Screening
  • Spatial Biology and Multiomics Research
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automated Single-Cell Sample Preparation System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Oncology Research, Immunology Research, Cell and Gene Therapy Research evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Automated Single-Cell Sample Preparation System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$841
2025
Forecast
$1735.1
2032
CAGR
10.9%
2025–2032
Regiões
5
global
Key companies
10x Genomics, Inc.BD BiosciencesMission Bio, Inc.Dolomite BioSingleron BiotechnologiesTakara Bio Inc.S2 Genomics, Inc.Cellenion SASU
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single-cell Isolation SystemsSingle-cell Library Preparation SystemsSingle-cell Dispensing SystemsTissue Dissociation and Nuclei Preparation SystemsIntegrated Multiomics Preparation PlatformsOthers
By Application
Oncology ResearchImmunology ResearchCell and Gene Therapy ResearchDrug Discovery and ScreeningSpatial Biology and Multiomics ResearchOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single-cell Isolation Systems
  • 3.1.3 Single-cell Library Preparation Systems
  • 3.1.4 Single-cell Dispensing Systems
  • 3.1.5 Tissue Dissociation and Nuclei Preparation Systems
  • 3.1.6 Integrated Multiomics Preparation Platforms
  • 3.1.7 Others
  • 3.1.8 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Oncology Research
  • 4.1.3 Immunology Research
  • 4.1.4 Cell and Gene Therapy Research
  • 4.1.5 Drug Discovery and Screening
  • 4.1.6 Spatial Biology and Multiomics Research
  • 4.1.7 Others
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 10x Genomics, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 BD Biosciences
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Mission Bio, Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Dolomite Bio
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Singleron Biotechnologies
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Takara Bio Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 S2 Genomics, Inc.
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Cellenion SASU
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 CYTENA GmbH
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Sphere Fluidics Limited
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Berkeley Lights, Inc. (PhenomeX)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 MGI Tech Co., Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Standard BioTools Inc.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 LevitasBio
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 NanoCellect Biomedical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Beijing Bestopcell Medical Technology Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Automated Single-Cell Sample Preparation System market size?
The global Automated Single-Cell Sample Preparation System market is estimated at US$ 841 million in 2025 (base year) and is projected to reach US$ 1.69 billion by 2032.
What growth rate is expected for the Automated Single-Cell Sample Preparation System market through 2032?
The market is expected to grow at a CAGR of 10.9% from 2026 to 2032, expanding from US$ 841 million in 2025 to US$ 1.69 billion in 2032, roughly 2.0 times its base-year value.
How is Automated Single-Cell Sample Preparation System defined?
Automated single cell sample preparation systems are advanced life science automation platforms designed for single cell sequencing, single cell multiomics, and cellular analysis workflows. These systems are primarily used for tissue dissociation, single cell or single nucleus suspension preparation, cell isolation, microfluidic encapsulation, barcode labeling, library preparation, and upstream sample processing.
How is the Automated Single-Cell Sample Preparation System market segmented by type?
By type, the market is segmented into Single-cell Isolation Systems, Single-cell Library Preparation Systems, Single-cell Dispensing Systems, Tissue Dissociation and Nuclei Preparation Systems, Integrated Multiomics Preparation Platforms and Others.
What are the key applications of Automated Single-Cell Sample Preparation System?
Key applications covered include Oncology Research, Immunology Research, Cell and Gene Therapy Research, Drug Discovery and Screening, Spatial Biology and Multiomics Research and Others.
Which companies are profiled in the Automated Single-Cell Sample Preparation System market report?
Key players profiled include 10x Genomics, BD Biosciences, Mission Bio, Dolomite Bio, Singleron Biotechnologies, Takara Bio Inc., S2 Genomics and Cellenion SASU, among 16 companies covered in total.
What geographies does the Automated Single-Cell Sample Preparation System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Automated Single-Cell Sample Preparation System?
Industry consolidation, platform acquisitions, and ecosystem integration have become increasingly active in recent years, particularly as vendors seek to combine single cell workflows with spatial biology, AI driven analytics, and laboratory automation systems.
Who should buy the Automated Single-Cell Sample Preparation System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Oncology Research, Immunology Research and Cell and Gene Therapy Research, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Automated Single-Cell Sample Preparation System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.